Clinical Trials Logo

Appetite Regulation clinical trials

View clinical trials related to Appetite Regulation.

Filter by:

NCT ID: NCT05610124 Recruiting - Obesity Clinical Trials

Postprandial Glycemia and Satiety of Meals With Potatoes, With and Without Protein

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The proposed study aims to simulate a meal eaten at home, where meals will provide a fixed amount of protein from beef or vegetarian substitute "meat" balls with ad libitum access to one of mashed potatoes, full-fat fries, or pasta. Postprandial glycemia (PPG), insulin, active ghrelin, satiety, amino acid response and food intake (FI) at the meal and again 3h later (after an ad libitum pizza meal) will be measured. In addition, post-meal PPG and satiety will be measured for one hour after the second meal.

NCT ID: NCT05590611 Recruiting - Clinical trials for Overweight and Obesity

Impact of Sourdough Bread Consumption on Long-term Energy Intake: A Pilot Study of Feasibility

SOBER
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The present study is a pilot study examining whether long-term sourdough bread consumption reduces energy intake and blood lipids levels over a period of 4 weeks in free-living normalweight and overweight participants.

NCT ID: NCT05587127 Recruiting - Dyspepsia Clinical Trials

Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia

Start date: November 30, 2022
Phase: N/A
Study type: Interventional

Randomized controlled trial of an exposure-based behavioral treatment (CBT) in adults with functional dyspepsia who meet criteria for avoidant/restrictive food intake disorder (ARFID) with weight loss.

NCT ID: NCT04788069 Completed - Energy Intake Clinical Trials

Effect of Sourdough Breads Consumption on Postprandial Responses, Satiety and Food Intake at Subsequent Meal

SUPPRESS
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

During this project the effect of different types of sourdough breads consumption on satiety, energy intake at subsequent meal and postprandial metabolic responses, will be investigated.

NCT ID: NCT04345029 Completed - Clinical trials for Overweight and Obesity

Effectiveness of a Natural Ingredient on Appetite Regulation

SAC
Start date: January 15, 2020
Phase: N/A
Study type: Interventional

Single-center, double-blind, double-crossed, randomized controlled clinical trial with two crossed branches, designed with the objective of evaluating the effect of the investigational product on satiety.

NCT ID: NCT03956732 Completed - Bone Health Clinical Trials

Effects of Milk Protein and Vitamin D on Children's Growth and Health

D-pro
Start date: June 20, 2019
Phase: N/A
Study type: Interventional

The purpose of D-pro is to investigate the combined and separate effects of milk protein and vitamin D on bone health, growth, muscle function, body composition and cardiometabolic health in 6-8-year-old children.

NCT ID: NCT03322514 Completed - Appetite Regulation Clinical Trials

Colonic Propionate, Appetite, and Weight Loss

ProAp
Start date: March 29, 2017
Phase: N/A
Study type: Interventional

The current protocol aims to investigate the impact of the propionate ester in conjugation with restricted diet on appetite and weight loss.

NCT ID: NCT03143868 Completed - Energy Intake Clinical Trials

Role of Acute Exercise Modality on Appetite Regulation and Energy Intake

Start date: June 14, 2017
Phase: N/A
Study type: Interventional

This study plans to learn more about how type of exercise influences measures of appetite regulation. In this study, investigators will be evaluating a resistance exercise session (using weight machines and free weights) and an aerobic exercise session (using a treadmill). Participants will also complete a sedentary control condition. A secondary purpose is to compare sex-based differences in appetite-indices in response to exercise. Therefore, the responses to aerobic and resistance exercise will also be compared between men and women.

NCT ID: NCT03025997 Completed - Appetite Regulation Clinical Trials

Lipid Encapsulation for Ileal Brake Activation

Start date: January 24, 2017
Phase: N/A
Study type: Interventional

This study evaluates the ability of encapsulation of orally applied lipids in a yoghurt snack to modify ad libitum food intake and satiety, without GI symptoms. Every subject receives two treatments (active, and placebo) on two different days, following a randomized cross-over design.

NCT ID: NCT02774486 Completed - Energy Intake Clinical Trials

Efficacy and Safety of IQP-AK-102 in Reducing Appetite

Start date: May 1, 2016
Phase: N/A
Study type: Interventional

The primary cause of being overweight is an imbalance in calories consumed and energy expenditure. A surplus in energy intake might result in body fat deposition and thereby body weight gain. Therefore, food intake regulation is crucial to control the body weight gain. Appetite regulation plays an important role in determining the food intake, which is a complex process influenced by the individual (physiology and psychology) and environment. Satiation (process that leads to the termination of eating) and satiety (decline in hunger, increase in fullness after a meal has finished) are the precursors of appetite regulation, which may be induced by various food components such as macronutrients, water, alcohol and non-digestible polysaccharides. High viscosity and swellable/bulking food components such as dietary fibre are expected to elicit stronger satiation/satiety than the macronutrients or clear liquid. Due to its unique physicochemical properties, dietary fibre has been recognized as potential ingredient that helps to enhance the sensation of satiety in the upper gut by increasing gastric distension and delaying gastric emptying, which subsequently reduces the food intake. IQP-AK-102 comprises of a proprietary blend of dietary fibres known to promote a feeling a fullness. The objectives of this study are to evaluate the efficacy and safety of IQP-AK-102 on appetite reduction in overweight subjects during a 4-weeks interval.